Search results for " Neovascularization"

showing 7 items of 57 documents

Efficacy and safety of ranibizumab with or without panretinal laser photocoagulation versus laser photocoagulation alone in proliferative diabetic re…

2019

Purpose Panretinal photocoagulation (PRP) is the current standard of care in proliferative diabetic retinopathy (PDR). However, treatment with anti-vascular endothelial growth factor agents might offer better patient outcomes with fewer side-effects. The PRIDE study aimed to assess the efficacy and safety of ranibizumab with or without PRP compared with PRP alone in patients with PDR. Methods A total of 106 PDR patients without diabetic macular oedema were randomized to receive ranibizumab 0.5 mg monotherapy (n = 35), PRP (n = 35) or combined ranibizumab 0.5 mg/PRP (n = 36). The primary objective of this 12-month, multicentre, phase II study was to investigate the change in area of retinal …

medicine.medical_specialtyVisual acuitygenetic structuresbusiness.industrySignificant differencePhases of clinical researchGeneral MedicineDiabetic retinopathyPanretinal laser photocoagulationmedicine.diseaseAlternative treatment03 medical and health sciencesOphthalmologyRetinal neovascularization0302 clinical medicineOphthalmology030221 ophthalmology & optometrymedicineRanibizumabmedicine.symptombusiness030217 neurology & neurosurgerymedicine.drugActa Ophthalmologica
researchProduct

Intravitreal ranibizumab for symptomatic drusenoid pigment epithelial detachment without choroidal neovascularization in age-related macular degenera…

2011

Roberto Gallego-Pinazo,1,2 Ana Marina Suelves-Cogollos1, Ester Francés-Muñoz,1 J María Millán,2,3 J Fernando Arevalo,4 J Luis Mullor,5 Manuel Díaz-Llopis,1,2,61Department of Ophthalmology, Hospital Universitario La Fe, Valencia, Spain; 2Centro de Investigación Biomédica en Red de Enfermedades Raras, Valencia, Spain; 3Department of Genetics, Hospital Universitario La Fe, Valencia, Spain; 4Retina and Vitreous Service, Clínica Oftalmológica Centro Caracas, Caracas, Venezuela; 5Unit of Experimental Ophthalmology, Fundación para la Investigación del Hospital Universitario La F…

medicine.medical_specialtyVisual acuitygenetic structureschoroidal neovascularizationOptical coherence tomographyOphthalmologymedicineMetamorphopsiadrusenoid pigment epithelial detachmentranibizumabage-related macular degenerationOriginal Researchsoft drusenmedicine.diagnostic_testbusiness.industryClinical OphthalmologyDiabetic retinopathyMacular degenerationmedicine.diseaseeye diseasesOphthalmologyChoroidal neovascularizationsense organsRanibizumabmedicine.symptomIntravitreal ranibizumabbusinessmedicine.drugClinical Ophthalmology
researchProduct

Morphologische und funktionelle Ergebnisse nach transpupillarer Thermotherapie (TTT) maligner Aderhautmelanome

2006

BACKGROUND The aim of this study was to evaluate the course of tumor regression and visual impairment in choroidal melanomas treated by transpupillary thermotherapy (TTT) alone. PATIENTS AND METHODS In a prospective, non-randomized analysis 26 patients suffering from primary choroidal melanoma (posterior to the equator with base < or = 12 and thickness < or = 4.5 mm) were treated with the TTT standard protocol and followed for 33 - 45 months. Fluorescein and ICG angiographies were performed initially and after tumor regression clinically. RESULTS 22 tumors were significantly flattened after 1 - 3 TTT sessions. 4 tumors required additional therapy with ruthenium plaque. Visual acuity remaine…

medicine.medical_specialtyVisual acuitygenetic structuresmedicine.diagnostic_testbusiness.industryFluorescein angiographymedicine.diseaseeye diseasesSurgeryOphthalmologychemistry.chemical_compoundChoroidal neovascularizationchemistryOphthalmologyAngiographymedicinesense organsFluoresceinmedicine.symptomProspective cohort studybusinessIndocyanine greenMacular edemaKlinische Monatsblätter für Augenheilkunde
researchProduct

Evolving European guidance on the medical management of neovascular age related macular degeneration

2006

BACKGROUND: Until recently, only two options were available for the treatment of choroidal neovascularisation (CNV) associated with age related macular degeneration (AMD)-thermal laser photocoagulation and photodynamic therapy with verteporfin (PDT-V). However, new treatments for CNV are in development, and data from phase III clinical trials of some of these pharmacological interventions are now available. In light of these new data, expert guidance is required to enable retina specialists with expertise in the management of AMD to select and use the most appropriate therapies for the treatment of neovascular AMD. METHODS: Consensus from a round table of European retina specialists was obt…

medicine.medical_specialtygenetic structuresBevacizumabAntibodies Monoclonal HumanizedTriamcinolone AcetonideMacular DegenerationCellular and Molecular NeuroscienceRanibizumabOphthalmologymedicineHumansPregnadienediolsEvidence-Based Medicinemedicine.diagnostic_testbusiness.industryAntibodies MonoclonalAptamers NucleotideMacular degenerationFluorescein angiographymedicine.diseaseVerteporfinChoroidal Neovascularizationeye diseasesSensory SystemsOphthalmologyTreatment Outcomemedicine.anatomical_structureChoroidal neovascularizationPhotochemotherapyPerspectivesense organsAnecortave acetateChoroidRanibizumabmedicine.symptombusinessmedicine.drugBritish Journal of Ophthalmology
researchProduct

Transpupillary thermotherapy (TTT) for age-related macular degeneration (AMD) – Is it time to say good-bye?

2010

Abstract Purpose To evaluate the effectiveness of transpupillary thermotherapy (TTT) for the closure of classic and occult subfoveal choroidal neovascularization (CNV) and to discuss whether TTT is a useful treatment modality for age-related macular degeneration (AMD). Materials and methods The present paper is a retrospective review of the clinical results from a patient group which was treated with TTT in the University Eye Clinic in Mainz. From January 2000 to December 2002, a total of 20 eyes of 20 patients with subfoveal CNV (due to AMD in 16 eyes, due to pathologic myopia in 4 eyes) received TTT. The procedure was delivered using an infrared diode laser at 810 nm, equipped with a modi…

medicine.medical_specialtygenetic structuresbusiness.industryDermatologyMacular degenerationmedicine.diseaseOcculteye diseasesLesionContact lensChoroidal neovascularizationAtrophyOphthalmologyOcclusionmedicineSurgeryMetamorphopsiasense organsmedicine.symptombusinessMedical Laser Application
researchProduct

Classic Choroidal Neovascularization

2009

Since Donald Gass’s pioneering work in 1967, which demonstrated the role of choroidal neovascularization (CNV) in wet (exudative) AMD, visible (classic) CNV, well demarcated and well-defined on fluorescein angiography, has become the most characteristic form of AMD.

medicine.medical_specialtygenetic structuresmedicine.diagnostic_testbusiness.industryFluorescein angiographyeye diseasesmedicine.anatomical_structureChoroidal neovascularizationOphthalmologymedicinesense organsmedicine.symptomOuter nuclear layerbusiness
researchProduct

Comparative study of post-natal retinal vascular development in mice models of iPLA2 inhibition and plasmalogen deficiency

2012

Purpose: Plasmalogens are particular phospholipids characterized by the presence of a vinyl-ether bond and of a polyunsaturated fatty acid (PUFA) at sn-1 and sn-2 positions of glycerol, respectively. Even if the plasmalogen content of organs and tissues is well documented, their biological functions are still enigmatic. Plasmalogen deficiency in DAPAT-/- mice leads to developmental abnormalities in retinal vasculature (Acar et al, ARVO 2007 E-Abstract 2978) and to persistent hyaloïd arteries. We hypothesize that plasmalogens regulate retinal vascular development through the liberation of PUFA by a plasmalogen-specific calcium-independent phospholipase A2 (iPLA2). We have performed a compara…

medicine.medical_specialtymicePlasmalogen[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionrétineBiologysourispost natal03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePhospholipase A2Internal medicine[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologymedicine[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs697 retinal neovascularization497 developmentchemistry.chemical_classificationRetina[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyRetinalGeneral Medicineeye diseases582 lipidsOphthalmology[SDV.AEN] Life Sciences [q-bio]/Food and NutritionEndocrinologymedicine.anatomical_structureBiochemistrychemistry[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organs030221 ophthalmology & optometryOptic nervebiology.protein[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgeryImmunostaining[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyAstrocytePolyunsaturated fatty acid
researchProduct